Navigation Links
Study identifies causes of bone loss in breast cancer survivors
Date:11/19/2008

MAYWOOD -- Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.

But a new study has found that cancer drugs aren't the only culprits. Among 64 breast cancer patients referred to a bone health clinic, 78 percent had at least one other cause of bone loss, including vitamin D deficiency, excessive calcium excretion in urine and an overactive parathyroid gland.

"Doctors evaluating breast cancer patients for possible bone loss should look further than cancer drugs," said Dr. Pauline Camacho, lead author of the study in the Journal of Clinical Oncology. Camacho is an associate professor in the department of medicine, division of endocrinology and metabolism, Loyola University Chicago Stritch School of Medicine.

A co-author of the study, Dr. Kathy Albain, said breast cancer survivors "are just like the normal population as they age in that bone loss can be due to many treatable causes." Albain is a professor in the Department of Medicine, division of hematology/oncology at Stritch.

Previous studies have found that chemotherapy drugs can cause bone loss. Studies also have found that a class of breast cancer drugs called aromatase inhibitors can decrease bone mineral density and increase the risk of fractures in postmenopausal women. Aromatase inhibitors decrease the body's production of estrogen. While estrogen feeds cancer, it also protects against osteoporosis. Aromatase inhibitors include letrozole (trade name, Femara), anastrazole (Arimidex) and exemestane (Aromasin).

Researchers reviewed charts of 238 consecutive postmenopausal patients who had osteoporosis or osteopenia and were referred to the Loyola's Osteoporosis and Metabolic Bone Disease Center from 2000 to 2006. (Osteopenia is lower than normal bone mineral density, but not low enough to be classified as osteoporosis.) The patients included 64 women with breast cancer referre
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
2. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
3. Rutgers researchers study cites media violence as critical risk factor for aggression
4. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
5. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
6. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
7. Study investigates Gore-tex-type device to stop strokes and mini-strokes
8. The smart way to study
9. Case Western Reserve University study examines working couples retirement patterns
10. Surgical study highlights pros and cons of gastric bypass surgery for severe obesity
11. Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...alth care reform details emerge, more entrepreneur...roups and business insurance premiums. Now, they a...s such as the Small Business Health Insurance Netw...Minneapolis, Minn. (PRWEB) July 3, 2009 -- The hea...ouse, which has entrepreneurs worried about how th...
(Date:7/2/2009)...o Support Principles to Govern Health Insurer Beha...-USNewswire/ -- Nearly nine out of ten voters (88%... much influence over how doctors care for their pa...he concept of a "Health Insurer Code of Conduct" t...or health insurance companies with respect to how ...
(Date:7/2/2009)...swire-USNewswire/ -- Acetaminophen is an ingredien...medicines to help relieve pain and reduce fever. ..., Tylenol and prescription brand names, Vicodin an...FDA met on June 30, 2009 to address liver related ...mittee voted 20-17 to urge the FDA to put a ban on...
(Date:7/2/2009)...Newswire/ -- Dr Daniel Goldberg, a leading New Jer... measure the effectiveness of using 5% Betadine ir...orldwide, highly contagious and often severe form ... visual impairment due to corneal involvement. , ...to register to participate in the Betadine for EKC...
Breaking Medicine News(10 mins):Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2
...ry measure and action against smoking in Scotland,.... Only adults// would be permitted to buy it. Min...endation, but they are likely to do so, given Jack... reduce smoking rates in Scotland. In the words o...
...e caused by AIDS, it was imperative that a giganti...linton Global Initiative teamed up to bring togeth...activists.The idea behind this exercise was to fin...ler. To involve the people CNN.com asked readers ...
...lic Health Service for Wales published, figures fo...y bugs, including MRSA. This step is taken to assu...ken by the health officials to protect the public....uired MRSA infection after a hip replacement opera...
...esearchers from the Mayo Clinic in Rochester, MN h...utaneous cryoablation //can be of significance in ...d is especially useful in patients who are not con...or the study, researchers treated 59 kidney tumors...
Other Medicine News:Health News:AIDS: from the heart stories about AIDS and you! 2Health News:AIDS: from the heart stories about AIDS and you! 3Health News:New Technique Destroys Kidney Tumors By Freezing Them 2
(Date:6/29/2009)...d, June 29 Vantia Therapeutics, an..., small molecule drugs,targeting large, underserv...m,a Phase IIa clinical trial of its lead developm...wed that oral VA106483 was successful in producing... in patients, as determined by,increased osmolali...
(Date:6/28/2009)... and TOKYO, June 29 , - Stu..., Sosei Group Corporation ("Sosei"; TSE Mothe... LSE: VEC) announce the commencement of a Phase II...-daily, long-acting muscarinic,antagonist (LAMA) ... disease,(COPD). NVA237 is a dry powder formulati...
(Date:6/26/2009)..., "Agendia,s Breast Cancer Recurrence Test MammaPr...onsensus Recommendations" issued,on 23 Jun 2009 1... be advised,that the subheadline was missing from...swire. Complete, corrected release follows: ,...Cancer Recurrence Test MammaPrint Included in,Int...
(Date:6/25/2009)...ical Experts Slated to Attend First National Sympo... -- The first national symposium designed to explo...d next week in New York City when thirteen top exp...their respective fields. The SUNY Youth Sports In...e health impacts that the $5 billion-a-year energy...
Breaking Medicine Technology:Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4Shareholder Class Action Filed Against Sequenom Inc by the Law Firm of Barroway Topaz Kessler Meltzer 26 Check LLP 45245 1Shareholder Class Action Filed Against Sequenom Inc by the Law Firm of Barroway Topaz Kessler Meltzer 26 Check LLP 45245 2Shareholder Class Action Filed Against Sequenom Inc by the Law Firm of Barroway Topaz Kessler Meltzer 26 Check LLP 45245 3Blue Cross and Blue Shield Funds Diabetes Education at Saints Mary and Elizabeth Medical Center 45243 1Blue Cross and Blue Shield Funds Diabetes Education at Saints Mary and Elizabeth Medical Center 45243 2APHA Applauds Climate Change Bill That Will Help Protect Public Health 45240 1U S Maternal Health Program 3A Marks 20 Years of Support to Mothers and Childbearing Women 45237 1U S Maternal Health Program 3A Marks 20 Years of Support to Mothers and Childbearing Women 45237 2
...ine out of 10 non-diabetic patients treated with,E...] , Additional average decrease of 20 mmHg in,sys...xforge over,reductions seen with previous monother...sure not,at treatment target levels[2] and most re... , , BASEL, Switzerland, May 21, 2007 - Exforg...
...XED DOSE COMBINATION WITH DIURETIC ACCEPTED FOR RE... NJ, 21 May 2007 -,Speedel (SWX: SPPN) today welc...als of SPP100 (aliskiren, Tekturna/Rasliez[1]),pre...fic Meeting,and Exposition of the American Society...results confirm the favourable safety and,efficacy...
Other Medicine Technology:Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: